27 Health Holdings Corp. Stock Analysis LRDG
Lord Global Corp. engages in developing, producing & distributing fictional and documentary films. The company is headquartered in Carson City, Nevada. The company went IPO on 2016-06-28. 27Health Inc. is focused on financing and marketing, healthcare-related products. The firm distributes the Virolens product in Asia, Australia, New Zealand and other Oceania countries. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology. The company uses a digital camera attached to a microscope to analyze saliva samples, with the data run through a computer that is trained to identify the virus from other cells, delivering a result in just 20 seconds. The Virolens system was trained to recognize the COVID-19 virus particles in saliva using a range of samples of COVID-19 virus provided by virologists working on the virus at the University of Bristol.
Read More 27 Health Holdings Corp (LRDG) Chart
Key Statistics of 27 Health Holdings Corp (LRDG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
8100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
268.90Avg. Volume
8100.00Dividend Yield
-Financial Metrics & Statements of 27 Health Holdings Corp (LRDG)
FAQ's for 27 Health Holdings Corp (LRDG)
- According to Musaffa’s Shariah screening methodology, 27 Health Holdings Corp (LRDG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.